View of Evolving Regulatory Positions and Legacy Data Challenges: A Case Study of Fludioxonil's Unknown Metabolite Fraction MF2 in European Active Ingredient Renewal

Return to Article Details Evolving Regulatory Positions and Legacy Data Challenges: A Case Study of Fludioxonil's Unknown Metabolite Fraction MF2 in European Active Ingredient Renewal Download Download PDF